Liver injury in Wilson's disease: An immunohistochemical study.


Journal

Advances in medical sciences
ISSN: 1898-4002
Titre abrégé: Adv Med Sci
Pays: Netherlands
ID NLM: 101276222

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 25 11 2021
revised: 04 03 2022
accepted: 16 04 2022
pubmed: 28 4 2022
medline: 26 10 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

Wilson's disease (WD) is an inherited disorder involving copper accumulation in the liver and brain. An important mechanism responsible for hepatocyte injury in WD is mitochondria destruction, although damage may also be caused by oxidative stress and lipid peroxidation. The study included 54 treated patients with WD without liver cirrhosis and 10 healthy controls. All patients had liver biopsy and immunohistochemical analysis of liver samples was performed using targeted staining for markers of mitochondrial injury (thioredoxin-2 [TRX2], cytochrome c oxidases subunit 2 [COX2], and cytochrome c oxidases complex IV subunit 4 isoform 1 [COX4-1]), of oxidative stress (peroxiredoxin-1 [PRDX1] and 8-hydroxyguanosine [8-OHdG]), and of lipid peroxidation (4-hydroxynonenal [4-HNE]). Expression, measured as mean strengths of intensity (SI) of immunohistochemical reactions per 5 fields of view, was significantly lower in patients with WD compared to controls for COX2 (2.9 vs 8.3), 8-OHdG (0.05 vs 3.8), TRX2 (4.9 vs 10.1), and PRDX1 (4.6 vs 10.1) (all P ​< ​10 Negligible COX4-1 and low COX2 expression in liver specimens may serve as markers of inner mitochondrial membrane injury in treated patients with WD and early stages of liver fibrosis.

Identifiants

pubmed: 35477108
pii: S1896-1126(22)00017-7
doi: 10.1016/j.advms.2022.04.003
pii:
doi:

Substances chimiques

Copper 789U1901C5
Cyclooxygenase 2 EC 1.14.99.1
Cytochromes c 9007-43-6
Biomarkers 0
Oxidoreductases EC 1.-
Peroxiredoxins EC 1.11.1.15
Thioredoxins 52500-60-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

203-207

Informations de copyright

Copyright © 2022 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interests.

Auteurs

Jowita Szeligowska (J)

Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.

Tomasz Ilczuk (T)

Department of Pathomorphology, Medical University of Warsaw, Warsaw, Poland.

Piotr Nehring (P)

Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.

Barbara Górnicka (B)

Department of Pathomorphology, Medical University of Warsaw, Warsaw, Poland.

Tomasz Litwin (T)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.

Anna Członkowska (A)

Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.

Adam Przybyłkowski (A)

Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. Electronic address: aprzybylkowski@wum.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH